Dupixent approved in the US as the first new targeted therapy in over a decade for chronic spontaneous urticaria Approval based on phase 3 studies demonstrating Dupixent significantly reduced itch and ...

Smoking is seriously injurious to health and it can cause long-term adverse effects on every organ in your body such as ...

Targeting of prestigious publication — and perhaps others — could signal a coming clash between journals and the Trump ...

Data to be presented supports development of rademikibart for patients with moderate-to-severe asthma or COPD experiencing an acute exacerbation – – Advancing rapid clinical development plan for ...

The medical devices market is projected to grow at a CAGR of 7% from 2025 to 2030, driven by technological advancements, a ...

Pfizer's Abrysvo and GSK's Arexvy both received FDA-approval b in 2024 to include immunization of adults aged 50 to 59 years at increased risk for RSV disease.

SNY beats Q1 estimates for earnings, while missing the same for sales. It expects earnings growth to rebound in 2025.

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

Wildfire smoke can have immediate and lasting effects on health, according to Dr. Sophia Meziani, an emergency medicine ...

UMass Memorial Health said its mobile integrated healthcare program reduced emergency room visits and saved up to $1.8 ...

New research highlights that severe obstructive sleep apnea (OSA) independently predicts elevated C-reactive protein (CRP) ...

To strengthen its U.S. presence, Roche is building up inventory, ramping up production at three of its U.S. plants and relocating one manufacturing site to the U.S. through a technology transfer, its ...